Debts
€126,301 94% of the balance sheet
Suppliers 0%Taxes and wages 0%Other 99%
Of this, €98,250 falls due within a year.
MEDCARE
Lifetime
2 annual accounts with figures on one time axispeak €66,905 (2024)
€37,952▼ 43.3%
peak €66,146 (2024)
€32,955▼ 50.2%
peak €8,102 (2025)
€8,102▲ 13.4%
€126,301▲ 91.0%
Board1 name since 2024
1 director
Documentsfilings and deeds
16-07-202615 days before the deadline
2025micro format
Gross margin from €66,905 to €37,952Result from €66,146 to €32,955Equity from €7,146 to €8,102Debts from €66,112 to €126,301Investments €25,977Cash from €60,254 to €93,575
Key points
from the 2025 annual accountsInvestments
€25,977 7.8 × depreciation
Green is investment, beige is depreciation. Machinery stands 352.4% higher than in 2024.
Position in the sector
6.0%
Lower solvency than 89% of companies in human health. Sector median 63.0% · 21,311 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,156 companies had the same profile as MEDCARE has now. Each dot stands for 6 companies, two years later.
94.1%
were still trading
2.8%
stopped another way
3.0%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,156 companies, not a prediction for MEDCARE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1011482841
Incorporation
Founding capital of €6,000, 6,000 shares · Founder: · Appointment: (statutory director) · published on 16-07-2024 · Gazette deed
First establishment
Vlasendaalstraat 71, Dilbeek
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| MEDCARE Dilbeek | €134,403 | €37,952 | 6.0% | - |
| Kinépraktijk Vander Stricht Laarne | €128,664 | €41,770 | 34.7% | - |
| De kinépraktijk 1560 Hoeilaart | €159,434 | €32,503 | 6.3% | - |
| KINERVA Halle | €120,161 | €32,000 | 18.3% | - |
| Kinesitherapie Lynn Beunnens Kapelle-op-den-Bos | €111,115 | €44,529 | 65.5% | - |
| ANOMA Antwerp | €110,949 | €38,104 | 12.2% | - |
| Gérardy Hardenne Beauraing | €135,654 | €40,226 | 74.8% | - |
These companies have the same main activity as MEDCARE: physiotherapy (NACE 86951). They are comparable in size and age: total assets between €111,000 and €159,000, founded between 2023 and 2024.
Official details
Source: KBO- Status
- Active since 12-07-2024Normal situation
- Activity
- PhysiotherapyNACE 86951
- Establishment unit
- 2.361.993.2531700 Dilbeek, since 12-07-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 28-09-2024
Annual accounts 2025
- ≈ €110,000estimated
- €134,403▲ 83.5%
- Filing
- Filed on 16-07-2026, 15 days before the end of the filing period
Insights on MEDCARE
MEDCARE has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €8,102 and a net result of €32,955.
Its solvency ranks better than 11% of 21,311 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MEDCARE
- What is the company number of MEDCARE?
- The company number of MEDCARE is 1011.482.841. The VAT number is the same number with BE in front: BE 1011.482.841.
- Where is MEDCARE based?
- The registered office is at Vlasendaalstraat 71, 1700 Dilbeek.Company details
- What does MEDCARE do?
- According to the KBO register, the main activity is physiotherapy (NACE 86951).
- What is the legal form of MEDCARE?
- MEDCARE is a private limited company (BV).
- When was MEDCARE founded?
- MEDCARE was founded on 12-07-2024.
- Is MEDCARE still active?
- Yes, MEDCARE is an active enterprise in the KBO register.
- What is the turnover of MEDCARE?
- The turnover in financial year 2025 is ≈ €110,000. This figure is estimated from the gross margin of €37,952 and 34 comparable companies (NACE 869). It probably lies between €87,000 and €160,000.Financials
- Is MEDCARE profitable?
- In financial year 2025, MEDCARE made a profit of €32,955.
- Where can I find the annual accounts of MEDCARE?
- MEDCARE filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MEDCARE due?
- MEDCARE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.